ESSENTIAL THERAPEUTICS INC has a total of 55 patent applications. Its first patent ever was published in 1996. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and biotechnology are CADENT THERAPEUTICS INC, COVEX SA and CANCER THERAPEUTICS CRC PTY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | Canada | 5 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | Israel | 5 | |
#5 | Norway | 5 | |
#6 | China | 4 | |
#7 | Estonia | 3 | |
#8 | Mexico | 3 | |
#9 | WIPO (World Intellectual Property Organization) | 3 | |
#10 | Argentina | 2 | |
#11 | Australia | 2 | |
#12 | Brazil | 2 | |
#13 | Slovakia | 2 | |
#14 | Malaysia | 1 | |
#15 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Biotechnology | |
#4 | Environmental technology | |
#5 | Measurement |
# | Name | Total Patents |
---|---|---|
#1 | Glinka Tomasz W | 16 |
#2 | Lee Ving J | 14 |
#3 | Cho Aesop | 14 |
#4 | Hecker Scott J | 13 |
#5 | Magee Andrew S | 10 |
#6 | Calkins Trevor | 10 |
#7 | Ala Paul J | 10 |
#8 | Moe Scott T | 10 |
#9 | Navia Manuel A | 9 |
#10 | Clement Jacob J | 7 |
Publication | Filing date | Title |
---|---|---|
US6689782B2 | Fungal efflux pump inhibitors | |
WO03000255A1 | Novel nitrofuran-containing heterocyclic compounds and uses thereof | |
AU2002243202A1 | Rapid antibiotic susceptibility test | |
US6551591B1 | Antibiotics from microbispora | |
US2002115650A1 | Cephalosporin antibiotics and prodrugs thereof | |
US6750038B1 | Rapid antibiotic susceptibility test | |
US6596723B1 | Fungal efflux pump inhibitors | |
US6723716B1 | 7-acylamino-3-heteroarylthio-3-cephem carboxylic acid antibiotics and prodrugs thereof | |
US6482921B1 | Uridyl peptide antibiotic (UPA) derivatives, their synthesis and use | |
US6514746B1 | Staphylococcus aureus histidine protein kinase essential genes | |
MY127641A | Cephalosporin antibiotics |